Remdesivir Efficacy in Coronavirus Disease

• Status: Completed
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

COVID 19 treatment using Remedesvir.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Chloroquine; Chloroquine diphosphate; Ivermectin; Niclosamide; Nitazoxanide; Remdesivir

Criteria

Inclusion Criteria:

• COVID 19 patients

Exclusion Criteria:

• allergy or contraindication to the drug